Show
Sort by
-
Potential new autoimmune target in inclusion body myositis
(2024) CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. In Clinical and Experimental Rheumatology 42(2). p.505-506 -
Low gene copy numbers of complement C4 and complement C4A deficiency are strong and highly significant genetic risk factors for idiopathic inflammatory myopathy and its major subgroups
(2023) CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. In Clinical and Experimental Rheumatology 41(2). p.416-416 -
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
-
Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics : 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 study
-
- Journal Article
- A1
- open access
Cardiovascular comorbidities in psoriatic arthritis : epidemiology and risk factors in two different European populations
-
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies
-
Rarities in rare : illuminating the microvascular and dermal status in juvenile localised scleroderma : a case series
-
Off-label use of mycophenolate mofetil in the treatment of rare and complex rheumatic connective tissue diseases
-
Health-related quality of life in patients with mixed connective tissue disease : a comparison with matched systemic sclerosis patients
-
The added value of a European Reference Network on rare and complex connective tissue and musculoskeletal diseases : insights after the first 5 years of the ERN ReCONNET